acetylcysteine has been researched along with xanthatin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Amamoto, T; Aramaki, H; Kudo, T; Matsuo, K; Nishimura, H; Noguchi, M; Okamoto, Y; Omiecinski, CJ; Shindo, M; Takeda, S; Yamaguchi, Y | 1 |
Amamoto, T; Aramaki, H; Koyachi, K; Matsumoto, K; Nishimura, H; Okamoto, Y; Shindo, M; Takeda, S; Yoshida, K | 1 |
Fang, XY; Ren, QC; Shen, XF; Tan, S; Wang, L; Zhang, H; Zhao, L | 1 |
Geng, Y; Liu, P; Liu, Y; Xie, Y; Zhang, L; Zhu, X | 1 |
4 other study(ies) available for acetylcysteine and xanthatin
Article | Year |
---|---|
(-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species.
Topics: Acetylcysteine; Antigens, Neoplasm; Blotting, Western; Cell Line, Tumor; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Female; Free Radical Scavengers; Furans; GADD45 Proteins; Glutathione; Half-Life; Humans; Insecticides; Intracellular Signaling Peptides and Proteins; Reactive Oxygen Species; RNA, Messenger; Topoisomerase II Inhibitors; Up-Regulation | 2013 |
(-)-Xanthatin induces the prolonged expression of c-Fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells.
Topics: Acetylcysteine; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Cell Division; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Free Radical Scavengers; Furans; GADD45 Proteins; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Proto-Oncogene Proteins c-fos; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Up-Regulation | 2013 |
A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
Topics: Acetylcysteine; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Furans; Glutathione; Humans; Janus Kinase 2; Liver Neoplasms; Malondialdehyde; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; STAT3 Transcription Factor | 2018 |
Xanthatin inhibits non-small cell lung cancer proliferation by breaking the redox balance.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Furans; Humans; Lung Neoplasms; Oxidation-Reduction; Reactive Oxygen Species | 2022 |